nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—Bone neoplasm—Riluzole—amyotrophic lateral sclerosis	0.113	0.139	CcSEcCtD
Eletriptan—Psychotic depression—Riluzole—amyotrophic lateral sclerosis	0.0257	0.0317	CcSEcCtD
Eletriptan—Major depression—Riluzole—amyotrophic lateral sclerosis	0.02	0.0247	CcSEcCtD
Eletriptan—Rheumatoid arthritis—Riluzole—amyotrophic lateral sclerosis	0.0178	0.022	CcSEcCtD
Eletriptan—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.0171	0.0905	CbGeAlD
Eletriptan—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.0166	0.0876	CbGeAlD
Eletriptan—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.0151	0.0186	CcSEcCtD
Eletriptan—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0168	CcSEcCtD
Eletriptan—Yawning—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0165	CcSEcCtD
Eletriptan—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.0132	0.0698	CbGeAlD
Eletriptan—Dementia—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0162	CcSEcCtD
Eletriptan—HTR7—pons—amyotrophic lateral sclerosis	0.013	0.069	CbGeAlD
Eletriptan—Hernia—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0142	CcSEcCtD
Eletriptan—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.011	0.0135	CcSEcCtD
Eletriptan—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0126	CcSEcCtD
Eletriptan—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00961	0.0119	CcSEcCtD
Eletriptan—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00961	0.0119	CcSEcCtD
Eletriptan—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00896	0.011	CcSEcCtD
Eletriptan—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00868	0.0459	CbGeAlD
Eletriptan—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00857	0.0106	CcSEcCtD
Eletriptan—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00857	0.0106	CcSEcCtD
Eletriptan—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00831	0.0102	CcSEcCtD
Eletriptan—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00798	0.00984	CcSEcCtD
Eletriptan—HTR1E—brainstem—amyotrophic lateral sclerosis	0.00796	0.0421	CbGeAlD
Eletriptan—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00783	0.00965	CcSEcCtD
Eletriptan—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00783	0.00965	CcSEcCtD
Eletriptan—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00775	0.00956	CcSEcCtD
Eletriptan—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00768	0.00947	CcSEcCtD
Eletriptan—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00761	0.00939	CcSEcCtD
Eletriptan—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00754	0.0093	CcSEcCtD
Eletriptan—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00747	0.00922	CcSEcCtD
Eletriptan—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00747	0.00922	CcSEcCtD
Eletriptan—Mania—Riluzole—amyotrophic lateral sclerosis	0.00741	0.00914	CcSEcCtD
Eletriptan—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00722	0.0089	CcSEcCtD
Eletriptan—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00704	0.00868	CcSEcCtD
Eletriptan—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00681	0.0084	CcSEcCtD
Eletriptan—HTR7—nerve—amyotrophic lateral sclerosis	0.00677	0.0358	CbGeAlD
Eletriptan—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.0067	0.00827	CcSEcCtD
Eletriptan—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00618	0.00762	CcSEcCtD
Eletriptan—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00609	0.00751	CcSEcCtD
Eletriptan—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00592	0.00731	CcSEcCtD
Eletriptan—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00589	0.00726	CcSEcCtD
Eletriptan—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00589	0.00726	CcSEcCtD
Eletriptan—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00585	0.00721	CcSEcCtD
Eletriptan—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00552	0.00681	CcSEcCtD
Eletriptan—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00549	0.00677	CcSEcCtD
Eletriptan—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00539	0.00664	CcSEcCtD
Eletriptan—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00539	0.00664	CcSEcCtD
Eletriptan—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00539	0.00664	CcSEcCtD
Eletriptan—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00532	0.00657	CcSEcCtD
Eletriptan—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.0053	0.028	CbGeAlD
Eletriptan—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0052	0.00642	CcSEcCtD
Eletriptan—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00514	0.00634	CcSEcCtD
Eletriptan—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00507	0.0268	CbGeAlD
Eletriptan—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00506	0.00624	CcSEcCtD
Eletriptan—HTR1F—nervous system—amyotrophic lateral sclerosis	0.00482	0.0255	CbGeAlD
Eletriptan—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00472	0.00582	CcSEcCtD
Eletriptan—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00468	0.00577	CcSEcCtD
Eletriptan—HTR1F—central nervous system—amyotrophic lateral sclerosis	0.00464	0.0245	CbGeAlD
Eletriptan—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00463	0.00571	CcSEcCtD
Eletriptan—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00458	0.00565	CcSEcCtD
Eletriptan—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00458	0.00565	CcSEcCtD
Eletriptan—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.0045	0.00555	CcSEcCtD
Eletriptan—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00437	0.00539	CcSEcCtD
Eletriptan—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00435	0.00537	CcSEcCtD
Eletriptan—Injury—Riluzole—amyotrophic lateral sclerosis	0.00425	0.00525	CcSEcCtD
Eletriptan—HTR1E—nervous system—amyotrophic lateral sclerosis	0.00417	0.0221	CbGeAlD
Eletriptan—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00513	CcSEcCtD
Eletriptan—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00513	CcSEcCtD
Eletriptan—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00414	0.00511	CcSEcCtD
Eletriptan—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00413	0.00509	CcSEcCtD
Eletriptan—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00411	0.00507	CcSEcCtD
Eletriptan—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00406	0.005	CcSEcCtD
Eletriptan—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00402	0.00496	CcSEcCtD
Eletriptan—HTR1E—central nervous system—amyotrophic lateral sclerosis	0.00402	0.0212	CbGeAlD
Eletriptan—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00482	CcSEcCtD
Eletriptan—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00482	CcSEcCtD
Eletriptan—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00475	CcSEcCtD
Eletriptan—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00475	CcSEcCtD
Eletriptan—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00466	CcSEcCtD
Eletriptan—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00377	0.0199	CbGeAlD
Eletriptan—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.0037	0.00457	CcSEcCtD
Eletriptan—HTR1F—brain—amyotrophic lateral sclerosis	0.00368	0.0195	CbGeAlD
Eletriptan—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00368	0.00454	CcSEcCtD
Eletriptan—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00365	0.0193	CbGeAlD
Eletriptan—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00445	CcSEcCtD
Eletriptan—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00427	CcSEcCtD
Eletriptan—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00425	CcSEcCtD
Eletriptan—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.0034	0.0042	CcSEcCtD
Eletriptan—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00417	CcSEcCtD
Eletriptan—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00417	CcSEcCtD
Eletriptan—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00417	CcSEcCtD
Eletriptan—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00406	CcSEcCtD
Eletriptan—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00325	0.00401	CcSEcCtD
Eletriptan—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00324	0.004	CcSEcCtD
Eletriptan—HTR1E—brain—amyotrophic lateral sclerosis	0.00319	0.0169	CbGeAlD
Eletriptan—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00385	CcSEcCtD
Eletriptan—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00384	CcSEcCtD
Eletriptan—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00379	CcSEcCtD
Eletriptan—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00377	CcSEcCtD
Eletriptan—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00304	0.0161	CbGeAlD
Eletriptan—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00366	CcSEcCtD
Eletriptan—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00364	CcSEcCtD
Eletriptan—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00364	CcSEcCtD
Eletriptan—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00362	CcSEcCtD
Eletriptan—HTR7—brainstem—amyotrophic lateral sclerosis	0.0029	0.0154	CbGeAlD
Eletriptan—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00356	CcSEcCtD
Eletriptan—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00288	0.0152	CbGeAlD
Eletriptan—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00351	CcSEcCtD
Eletriptan—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00349	CcSEcCtD
Eletriptan—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00275	0.0034	CcSEcCtD
Eletriptan—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00335	CcSEcCtD
Eletriptan—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00332	CcSEcCtD
Eletriptan—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00332	CcSEcCtD
Eletriptan—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00331	CcSEcCtD
Eletriptan—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0033	CcSEcCtD
Eletriptan—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00329	CcSEcCtD
Eletriptan—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00327	CcSEcCtD
Eletriptan—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00301	CcSEcCtD
Eletriptan—Chills—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00299	CcSEcCtD
Eletriptan—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00298	CcSEcCtD
Eletriptan—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00295	CcSEcCtD
Eletriptan—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00234	0.0124	CbGeAlD
Eletriptan—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00286	CcSEcCtD
Eletriptan—Tension—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00285	CcSEcCtD
Eletriptan—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00284	CcSEcCtD
Eletriptan—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00282	CcSEcCtD
Eletriptan—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00281	CcSEcCtD
Eletriptan—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00279	CcSEcCtD
Eletriptan—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00272	CcSEcCtD
Eletriptan—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00269	CcSEcCtD
Eletriptan—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00268	CcSEcCtD
Eletriptan—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.00217	0.0115	CbGeAlD
Eletriptan—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00267	CcSEcCtD
Eletriptan—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00265	CcSEcCtD
Eletriptan—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00262	CcSEcCtD
Eletriptan—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00261	CcSEcCtD
Eletriptan—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00211	0.0026	CcSEcCtD
Eletriptan—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00211	0.0026	CcSEcCtD
Eletriptan—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00257	CcSEcCtD
Eletriptan—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00255	CcSEcCtD
Eletriptan—Cough—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00253	CcSEcCtD
Eletriptan—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00252	CcSEcCtD
Eletriptan—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00251	CcSEcCtD
Eletriptan—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00203	0.0107	CbGeAlD
Eletriptan—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00247	CcSEcCtD
Eletriptan—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00247	CcSEcCtD
Eletriptan—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.002	0.00246	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00246	CcSEcCtD
Eletriptan—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00244	CcSEcCtD
Eletriptan—HTR1B—nervous system—amyotrophic lateral sclerosis	0.00197	0.0104	CbGeAlD
Eletriptan—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00242	CcSEcCtD
Eletriptan—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00239	CcSEcCtD
Eletriptan—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00237	CcSEcCtD
Eletriptan—HTR1D—nervous system—amyotrophic lateral sclerosis	0.00191	0.0101	CbGeAlD
Eletriptan—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.0019	0.01	CbGeAlD
Eletriptan—Shock—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00233	CcSEcCtD
Eletriptan—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00189	0.00999	CbGeAlD
Eletriptan—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00232	CcSEcCtD
Eletriptan—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00231	CcSEcCtD
Eletriptan—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00187	0.0023	CcSEcCtD
Eletriptan—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00229	CcSEcCtD
Eletriptan—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00184	0.00973	CbGeAlD
Eletriptan—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00226	CcSEcCtD
Eletriptan—HTR7—spinal cord—amyotrophic lateral sclerosis	0.00181	0.00955	CbGeAlD
Eletriptan—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00222	CcSEcCtD
Eletriptan—HTR2B—nervous system—amyotrophic lateral sclerosis	0.00178	0.0094	CbGeAlD
Eletriptan—CYP2A6—brain—amyotrophic lateral sclerosis	0.00177	0.00934	CbGeAlD
Eletriptan—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00216	CcSEcCtD
Eletriptan—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00214	CcSEcCtD
Eletriptan—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00213	CcSEcCtD
Eletriptan—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00211	CcSEcCtD
Eletriptan—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00171	0.00905	CbGeAlD
Eletriptan—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00211	CcSEcCtD
Eletriptan—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00209	CcSEcCtD
Eletriptan—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00206	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00205	CcSEcCtD
Eletriptan—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00204	CcSEcCtD
Eletriptan—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00165	0.00872	CbGeAlD
Eletriptan—Pain—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00203	CcSEcCtD
Eletriptan—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00203	CcSEcCtD
Eletriptan—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00159	0.00842	CbGeAlD
Eletriptan—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00195	CcSEcCtD
Eletriptan—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00194	CcSEcCtD
Eletriptan—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00153	0.00811	CbGeAlD
Eletriptan—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00188	CcSEcCtD
Eletriptan—HTR7—nervous system—amyotrophic lateral sclerosis	0.00152	0.00805	CbGeAlD
Eletriptan—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00187	CcSEcCtD
Eletriptan—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00187	CcSEcCtD
Eletriptan—HTR1B—brain—amyotrophic lateral sclerosis	0.00151	0.00797	CbGeAlD
Eletriptan—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.0015	0.00792	CbGeAlD
Eletriptan—HTR7—central nervous system—amyotrophic lateral sclerosis	0.00147	0.00775	CbGeAlD
Eletriptan—HTR1D—brain—amyotrophic lateral sclerosis	0.00146	0.00772	CbGeAlD
Eletriptan—HTR7—cerebellum—amyotrophic lateral sclerosis	0.00143	0.00757	CbGeAlD
Eletriptan—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00175	CcSEcCtD
Eletriptan—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00138	0.0017	CcSEcCtD
Eletriptan—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00168	CcSEcCtD
Eletriptan—HTR2B—brain—amyotrophic lateral sclerosis	0.00136	0.00718	CbGeAlD
Eletriptan—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00162	CcSEcCtD
Eletriptan—ABCB1—embryo—amyotrophic lateral sclerosis	0.0013	0.00685	CbGeAlD
Eletriptan—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00157	CcSEcCtD
Eletriptan—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.00125	0.0066	CbGeAlD
Eletriptan—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00151	CcSEcCtD
Eletriptan—HTR1A—brain—amyotrophic lateral sclerosis	0.00122	0.00644	CbGeAlD
Eletriptan—Rash—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00149	CcSEcCtD
Eletriptan—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00149	CcSEcCtD
Eletriptan—Headache—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00149	CcSEcCtD
Eletriptan—HTR7—brain—amyotrophic lateral sclerosis	0.00116	0.00615	CbGeAlD
Eletriptan—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00141	CcSEcCtD
Eletriptan—PTGS1—nervous system—amyotrophic lateral sclerosis	0.00105	0.00556	CbGeAlD
Eletriptan—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.00101	0.00535	CbGeAlD
Eletriptan—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000879	0.00465	CbGeAlD
Eletriptan—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000864	0.00457	CbGeAlD
Eletriptan—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000846	0.00447	CbGeAlD
Eletriptan—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000832	0.0044	CbGeAlD
Eletriptan—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000828	0.00438	CbGeAlD
Eletriptan—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000814	0.0043	CbGeAlD
Eletriptan—PTGS1—brain—amyotrophic lateral sclerosis	0.000804	0.00425	CbGeAlD
Eletriptan—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000738	0.0039	CbGeAlD
Eletriptan—CYP2D6—brain—amyotrophic lateral sclerosis	0.000661	0.00349	CbGeAlD
Eletriptan—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000622	0.00329	CbGeAlD
Eletriptan—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000599	0.00317	CbGeAlD
Eletriptan—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000585	0.00309	CbGeAlD
Eletriptan—ABCB1—brain—amyotrophic lateral sclerosis	0.000475	0.00251	CbGeAlD
